Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination
Authors
Keywords
Multiple sclerosis, Cortical demyelination, Oligodendrocytes, Oligodendrocyte precursors, Targeted cortical EAE
Journal
ACTA NEUROPATHOLOGICA
Volume 128, Issue 2, Pages 231-246
Publisher
Springer Nature
Online
2014-02-24
DOI
10.1007/s00401-014-1260-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats
- (2013) Christopher Gardner et al. BRAIN
- Neuroprotective intervention by interferon-γ blockade prevents CD8+T cell–mediated dendrite and synapse loss
- (2013) Mario Kreutzfeldt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Focal Immune-Mediated White Matter Demyelination Reveals an Age-Associated Increase in Axonal Vulnerability and Decreased Remyelination Efficiency
- (2012) David W. Hampton et al. AMERICAN JOURNAL OF PATHOLOGY
- Cortical remyelination: A new target for repair therapies in multiple sclerosis
- (2012) Ansi Chang et al. ANNALS OF NEUROLOGY
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- Olig2-dependent developmental fate switch of NG2 cells
- (2012) X. Zhu et al. DEVELOPMENT
- Measurement and clinical effect of grey matter pathology in multiple sclerosis
- (2012) Jeroen JG Geurts et al. LANCET NEUROLOGY
- Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis
- (2011) Natalia Manrique-Hoyos et al. ANNALS OF NEUROLOGY
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study
- (2011) M Calabrese et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Cortical lesions in multiple sclerosis
- (2010) Massimiliano Calabrese et al. Nature Reviews Neurology
- Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
- (2009) Massimiliano Calabrese et al. ARCHIVES OF NEUROLOGY
- Cortical pathology in multiple sclerosis
- (2009) Christine Stadelmann et al. CURRENT OPINION IN NEUROLOGY
- Accumulation of cortical lesions in MS: relation with cognitive impairment
- (2009) SD Roosendaal et al. Multiple Sclerosis Journal
- Remyelination capacity of the MS brain decreases with disease chronicity
- (2009) T. Goldschmidt et al. NEUROLOGY
- Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
- (2008) T. Kuhlmann et al. BRAIN
- Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord
- (2008) C P Gilmore et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency
- (2008) Siming Shen et al. NATURE NEUROSCIENCE
- Remyelination in the CNS: from biology to therapy
- (2008) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started